97 related articles for article (PubMed ID: 7008408)
21. [Renin-angiotensin-aldosterone system in thyroid disorders].
Marcisz C
Postepy Hig Med Dosw; 2000; 54(4):519-35. PubMed ID: 11016270
[TBL] [Abstract][Full Text] [Related]
22. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
[TBL] [Abstract][Full Text] [Related]
23. Renin content of the kidney in renal and adrenal diseases associated with hypertension.
Kawabe K; Sokabe H
Surgery; 1966 Nov; 60(5):986-92. PubMed ID: 5928115
[No Abstract] [Full Text] [Related]
24. [Hypertension plus hypokalemia should direct the line of thoughts toward Liddle's syndrome].
Svenarud P; Palmér M
Lakartidningen; 1999 Oct; 96(43):4667-8. PubMed ID: 10575877
[No Abstract] [Full Text] [Related]
25. Comparative biochemistry of renins and angiotensins in the vertebrates.
Nakajima T; Khosla MC; Sakakibara S
Jpn Heart J; 1978 Sep; 19(5):799-805. PubMed ID: 731941
[TBL] [Abstract][Full Text] [Related]
26. [Erythropoietin, renin, aldosterone, and blood volume in primary and secondary polycythemia].
Werning C; Essers U; Schulte P; Schweikert HU; Stiel D; Vetter W; Weidmann P; Siegenthaler W
Klin Wochenschr; 1971 Jan; 49(1):13-9. PubMed ID: 4322910
[No Abstract] [Full Text] [Related]
27. Endocrine arterial hypertension: diagnostic approach in clinical practice.
Mazza A; Zamboni S; Armigliato M; Zennaro R; Cuppini S; Rempelou P; Rubello D; Pessina AC
Minerva Endocrinol; 2008 Jun; 33(2):127-46. PubMed ID: 18272953
[TBL] [Abstract][Full Text] [Related]
28. VARIATIONS IN PLASMA RENIN CONCENTRATION IN SEVERAL PHYSIOLOGICAL AND PATHOLOGICAL STATES.
BROWN JJ; DAVIES DL; LEVER AF; ROBERTSON JI
Can Med Assoc J; 1964 Jan; 90(4):201-6. PubMed ID: 14111717
[No Abstract] [Full Text] [Related]
29. The study of renin-angiotensin-aldosterone in experimental diabetes mellitus.
Ustündag B; Cay M; Naziroglu M; Dilsiz N; Crabbe MJ; Ilhan N
Cell Biochem Funct; 1999 Sep; 17(3):193-8. PubMed ID: 10451540
[TBL] [Abstract][Full Text] [Related]
30. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
[TBL] [Abstract][Full Text] [Related]
31. [Radioimmunologic determination of renin-angiotensin-aldosterone in adrenal gland tumors].
Slavnov VN; Iakovlev AA; Iugrinov OG; Gandzha TI
Med Radiol (Mosk); 1983 Feb; 28(2):42-6. PubMed ID: 6835045
[No Abstract] [Full Text] [Related]
32. The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.
Jedrusik P; Januszewicz A; Busjahn A; Wocial B; Ignatowska-Switalska H; Strelau J; C Luft F; Januszewicz W
Kardiol Pol; 2004 Nov; 61(11):423-9; discussion 430. PubMed ID: 15883590
[TBL] [Abstract][Full Text] [Related]
33. ALDOSTERONE SECRETION AND VARIOUS FORMS OF HYPERTENSIVE VASCULAR DISEASE.
LARAGH JH; CANNON PJ; AMES RP
Ann Intern Med; 1963 Jul; 59():117-20. PubMed ID: 14042605
[No Abstract] [Full Text] [Related]
34. [The effect of phenothiazine derivatives that inhibit glucocorticoid receptor function on the state of the renin-angiotensin system].
Golikov PP; Kladiev AA; Nikolaeva NIu; Babaian KA
Eksp Klin Farmakol; 1993; 56(5):21-3. PubMed ID: 8312802
[TBL] [Abstract][Full Text] [Related]
35. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
Hiramatsu K; Yamada T; Yukimura Y; Komiya I; Ichikawa K; Ishihara M; Nagata H; Izumiyama T
Arch Intern Med; 1981 Nov; 141(12):1589-93. PubMed ID: 7030245
[TBL] [Abstract][Full Text] [Related]
36. Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects.
Brown MJ; Coltart J; Gunewardena K; Ritter JM; Auton TR; Glover JF
Clin Sci (Lond); 2004 Aug; 107(2):167-73. PubMed ID: 15040783
[TBL] [Abstract][Full Text] [Related]
37. Tissue renin angiotensin systems: theoretical implications for the development of hyperkalemia using angiotensin-converting enzyme inhibitors.
Schlueter W; Keilani T; Batlle DC
Am J Med Sci; 1994 Feb; 307 Suppl 1():S81-6. PubMed ID: 8141171
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
Oda N; Takeda Y; Zhu A; Usukura M; Yoneda T; Takata H; Mabuchi H
Hypertens Res; 2006 Jan; 29(1):9-14. PubMed ID: 16715648
[TBL] [Abstract][Full Text] [Related]
39. [What is the purpose of dual or triple inhibition of the renin-angiotensin-aldosterone system?].
Legrand D; Krzesinski JM; Scheen AJ
Rev Med Suisse; 2008 Aug; 4(168):1792-7. PubMed ID: 18814762
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of primary aldosteronism: from screening to subtype differentiation.
Mulatero P; Dluhy RG; Giacchetti G; Boscaro M; Veglio F; Stewart PM
Trends Endocrinol Metab; 2005 Apr; 16(3):114-9. PubMed ID: 15808809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
